Filed: 2/17/2026ACC: 0001012975-26-000154
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $369.45M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$369.45M
Total AUM (reported)
11.74M
Total Shares
Allocation by class
ALLWRLD EX US$219.95M59.5%
VALUE ETF$99.31M26.9%
COM$22.64M6.1%
MSCI INDIA ETF$19.98M5.4%
COM NEW$4.77M1.3%
TR UNIT$2.80M0.8%
*W EXP 08/01/203$3.4K0.0%
Portfolio Concentration
Top 3$339.24M91.8%
4–10$29.48M8.0%
11–25$726.1K0.2%
Top 3 weight
91.8%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 11.74M
Sole
Full voting authority
11.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
VANGUARD INTL EQUITY INDEX F
SOLEShares2.99M
TypeSH
Market value$219.95M
59.53%
Sole
2.99M
Shared
0.00
None
0.00
VANGUARD INDEX FDS
SOLEShares520K
TypeSH
Market value$99.31M
26.88%
Sole
520K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares369.60K
TypeSH
Market value$19.98M
5.41%
Sole
369.60K
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$8.50M
2.30%
Sole
1.57M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares989.41K
TypeSH
Market value$8.09M
2.19%
Sole
989.41K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.63M
TypeSH
Market value$3.28M
0.89%
Sole
2.63M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares4.10K
TypeSH
Market value$2.80M
0.76%
Sole
4.10K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares82.23K
TypeSH
Market value$2.79M
0.75%
Sole
82.23K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.31M
TypeSH
Market value$2.04M
0.55%
Sole
1.31M
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares87.70K
TypeSH
Market value$1.98M
0.54%
Sole
87.70K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$722.7K
0.20%
Sole
1.02M
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares170.83K
TypeSH
Market value$3.4K
<0.01%
Sole
170.83K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VANGUARD INTL EQUITY INDEX FSOLE | ALLWRLD EX US | 2.99M | SH | $219.95M 59.53% | 2.99M | 0.00 | 0.00 |
VANGUARD INDEX FDSSOLE | VALUE ETF | 520K | SH | $99.31M 26.88% | 520K | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 369.60K | SH | $19.98M 5.41% | 369.60K | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $8.50M 2.30% | 1.57M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 989.41K | SH | $8.09M 2.19% | 989.41K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.63M | SH | $3.28M 0.89% | 2.63M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 4.10K | SH | $2.80M 0.76% | 4.10K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM NEW | 82.23K | SH | $2.79M 0.75% | 82.23K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.31M | SH | $2.04M 0.55% | 1.31M | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 87.70K | SH | $1.98M 0.54% | 87.70K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 1.02M | SH | $722.7K 0.20% | 1.02M | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/203 | 170.83K | SH | $3.4K <0.01% | 170.83K | 0.00 | 0.00 |